Esmo22: Toni Choueiri, Md | Dana-Farber Cancer Institute

ESMO22: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Toni Choueiri, MD, Dana-Farber Cancer Institute, Medical Oncology

Dana-Farber Cancer Institute

ASCO23: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ESMO 2022: Renal roundup

ESMO22: Glenn Hanna, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Kidney Cancer CLEAR Trial biomarker analysis: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ASCOGU24: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Lifetime Achievement Award 2023– International track: Dr. Toni Choueiri Dana-Farber Cancer Institute

King Hussein Cancer Foundation and Center

ESMO24: Toni Choueiri, MD, TiNivo in Kidney Cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Kidney Cancer JAVELIN 101: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ESMO22: Breast cancer research by Sara Tolaney, MD (TROPiCS) | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ESMO22: Breast cancer research by Sara Tolaney, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ESMO23: Toni Choueiri, MD LITESPARK-003 | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Kidney cancer research: follow-up on immunotherapy after surgery | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ASCO22: Kidney Cancer research by Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ESMO23: Toni Choueiri, MD LITESPARK-005 | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

ASCO GU23 Toni Choueiri, MD: KEYNOTE-564 subgroup analysis | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Cancer Research, Best of 2010s: Toni Choueiri, MD

Dana-Farber Cancer Institute

ASCO GU23 Triplet therapy in kidney cancer: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute